Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study

Abstract

Teriparatide is the first anabolic agent for osteoporosis, and this analysis aimed to understand responses to teriparatide in Chinese patients with established osteoporosis in subgroups. In this Phase III study of teriparatide in China, 362 patients were randomized at a 2:1 ratio to receive subcutaneous teriparatide (20 μg/day) or intranasal salmon… (More)
DOI: 10.2147/CIA.S140900

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Lu2017ResponseTT, title={Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study}, author={Chunyan Lu and Yun Chen and Bin Zhang and Yu Chen and Fan Bai and Decai Chen}, booktitle={Clinical interventions in aging}, year={2017} }